triethylenephosphoramide has been researched along with Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blykers, A; Bormans, G; Caveliers, V; Cleeren, F; D'hoe, K; D'Huyvetter, M; De Baetselier, P; Devoogdt, N; Heemskerk, J; Lahoutte, T; Laoui, D; Raes, G; Schoonooghe, S; Van Ginderachter, JA; Vaneycken, I; Xavier, C | 1 |
| Beijnen, JH; Dalesio, O; de Jonge, ME; Huitema, AD; Mathôt, RA; Rodenhuis, S | 1 |
| CRAIG, AW; JACKSON, H | 1 |
| CHERNOV, VA; ZAKHROVA ZH, F | 1 |
| GRECO, T | 1 |
| Beijnen, JH; de Jonge, ME; Hillebrand, MJ; Huitema, AD; Rodenhuis, S; Rosing, H; van Dam, SM | 1 |
| Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM | 1 |
| Lytkin, GV | 1 |
| Beijnen, JH; Huitema, AD; Mathôt, RA; Rodenhuis, S; Schellens, JH; Tibben, MM | 1 |
| Aoki, K; Baba, T; Kanematsu, T; Kidera, Y; Kimura, M | 1 |
| Cole, D; DeLap, RJ; DeVito, J; Engstrom, PF; LaCreta, F; Litwin, S; O'Dwyer, PJ; Peter, R; Poplack, D; Tartaglia, L | 1 |
| Abendroth, K; Siering, VH | 1 |
2 review(s) available for triethylenephosphoramide and Neoplasms
| Article | Year |
|---|---|
Tris(1-aziridinyl)phosphine oxide.
Topics: Animals; Azirines; Carcinogens; Dogs; Drug Evaluation, Preclinical; Female; Genes, Lethal; Genes, Recessive; Lethal Dose 50; Male; Mutation; Neoplasms; Pregnancy; Rabbits; Rats; Species Specificity; Triethylenephosphoramide | 1975 |
[Principles of the effect of cytostatics].
Topics: Antineoplastic Agents; Asparaginase; Cell Division; Chlorambucil; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Triaziquone; Triethylenephosphoramide; Vincristine | 1974 |
2 trial(s) available for triethylenephosphoramide and Neoplasms
| Article | Year |
|---|---|
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide | 2005 |
Phase I/pharmacokinetic reevaluation of thioTEPA.
Topics: Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutrophils; Thiotepa; Thrombocytopenia; Triethylenephosphoramide | 1991 |
9 other study(ies) available for triethylenephosphoramide and Neoplasms
| Article | Year |
|---|---|
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Topics: Animals; Autoradiography; Camelids, New World; Fluorine Radioisotopes; Fluorobenzenes; Humans; Hydrogen-Ion Concentration; Lectins, C-Type; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Cell Surface; Single-Domain Antibodies; Tissue Distribution; Triethylenephosphoramide | 2015 |
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thiotepa; Triethylenephosphoramide | 2002 |
The metabolism of 32P-labelled triethylenephosphoramide in relation to its anti-tumour activity.
Topics: Animals; Humans; Neoplasms; Neoplasms, Experimental; Phosphorus; Phosphorus, Dietary; Triethylenephosphoramide | 1955 |
[Effects of triethylene phosphoramide on nucleic acid metabolism in neoplasm and various organs of animals with transplanted tumors (rat sarcoma 45)].
Topics: Antineoplastic Agents; Neoplasm Transplantation; Neoplasms; Nucleic Acids; Phosphoramides; Sarcoma; Triethylenephosphoramide | 1957 |
[Triethylene-phosphoramide or thio-TEPA in therapy of recurrent cancer of the breast].
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasms; Phosphoramides; Thiotepa; Triethylenephosphoramide | 1959 |
Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ion
Topics: Antineoplastic Agents, Alkylating; Chromatography, High Pressure Liquid; Cyclophosphamide; Drug Monitoring; Humans; Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Thiotepa; Triethylenephosphoramide | 2004 |
[Endolymphatic use of solutions of alkylating substances in a mixture with iodolipol in malignant neoplasms].
Topics: Alkylating Agents; Cyclophosphamide; Drug Evaluation; Female; Humans; Injections, Intralymphatic; Iodized Oil; Lymphatic Metastasis; Lymphography; Male; Neoplasms; Solutions; Thiotepa; Time Factors; Triethylenephosphoramide | 1981 |
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy.
Topics: Adolescent; Adult; Algorithms; Analysis of Variance; Antineoplastic Agents, Alkylating; Area Under Curve; Bayes Theorem; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Population; Thiotepa; Triethylenephosphoramide | 2001 |
Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Carbazilquinone; Carcinoma, Ehrlich Tumor; Chromomycins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Edema; Female; Hot Temperature; Mice; Mitomycins; Muscular Atrophy; Neoplasms; Nitrogen Mustard Compounds; Regional Blood Flow; Sarcoma, Experimental; Time Factors; Triethylenephosphoramide | 1976 |